BARCLAYS PLC - INNATE PHARMA S A ownership

INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 12 filers reported holding INNATE PHARMA S A in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of INNATE PHARMA S A
ValueSharesWeighting
Q3 2023$10.0%4120.0%0.00%
Q2 2023$10.0%4120.0%0.00%
Q1 2023$1
-50.0%
4120.0%0.00%
Q4 2022$2412
+235.0%
0.00%
Q3 2022$0
-100.0%
123
-94.4%
0.00%
Q2 2022$6,000
-45.5%
2,179
-36.1%
0.00%
Q1 2022$11,0003,4110.00%
Other shareholders
INNATE PHARMA S A shareholders Q4 2022
NameSharesValueWeighting ↓
Optiver Holding B.V. 181,944$491,0000.00%
BANK OF AMERICA CORP /DE/ 175,229$473,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 16,856$46,0000.00%
CREDIT SUISSE AG/ 1,981$5,0000.00%
CITIGROUP INC 55$00.00%
MORGAN STANLEY 46,598$126,0000.00%
BlackRock Inc. 497,275$1,343,0000.00%
CAPTRUST FINANCIAL ADVISORS 905$2,0000.00%
Steward Partners Investment Advisory, LLC 500$1,0000.00%
View complete list of INNATE PHARMA S A shareholders